NOV 18, 2019 08:58 AM PST

Evaluating the Genetic Damage Caused by Cancer Treatments

WRITTEN BY: Carmen Leitch

Throughout our lives, our bodies have to constantly replenish old cells with new ones; a cell can give rise to two new ones and the genome has to be copied and divided evenly between the two new cells every time. Our cells are also exposed to a wide variety of detrimental environmental influences, like toxins or UV rays. Inevitably, errors can arise in the genome, and while some are harmless, others can lead to uncontrolled cell growth - cancerous tumors. During cancer treatment, therapeutics take aim at tumor cells, and some target their DNA. While these treatments are meant to impact only cancerous cells, they can also cause collateral damage to healthy cells.

Genetic mutations induced by cancer treatment can have a characteristic pattern, called a mutational signature. Researchers at IRB Barcelona have identified these genetic footprints and have for the first time been able to calculate the genetic toxicity of some of these treatments. / Credit: Claudia Arnedo, IRB Barcelona.

In new work reported in Nature Genetics, a team of researchers has assessed how six widely used cancer therapies affect the genome. Five of these treatments are chemotherapies (platinum-based drugs and capecitabine) and one is radiotherapy, which uses radiation.

"It is important to remember that chemotherapies are highly efficient for the treatment of cancer," noted the first author of the study Oriol Pich, a graduate student at the Institute for Research in Biomedicine (IRB Barcelona). "But long-term side effects have also been reported in some patients. Studying the DNA mutations that occur in cells as a result of chemotherapies is the first step towards understanding the relationship between these mutations and the long-term side effects of these treatments."

In this work, the researchers used genetic sequences obtained from metastatic tumors from about 3,500 cancer patients (provided by the Hartwig Medical Foundation in the Netherlands) and data about the treatments the patients got. Led by ICREA researcher Núria López-Bigas, head of the Biomedical Genomics Laboratory at the IRB Barcelona, the scientists were able to find patterns in the genetic mutations in the tumors, called a mutational footprint.

"Once this footprint has been identified, we can quantify the DNA mutations that have been caused by each kind of chemotherapy, as well as those caused by treatment combinations," explained López-Bigas. "We have compared these numbers with the genetic alterations caused by natural endogenous processes. We have calculated that, during treatment, some of these chemotherapies cause DNA mutations at a rate that is between 100 and 1000 times faster than what normally occurs in a cell."

Now that the researchers know more about the impact of these treatments, they can be applied optimally. "The aim is to maximize the beneficial effects of chemotherapies by destroying tumor cells while minimizing the number of mutations caused in the healthy cells of the patients. This would be achieved through a careful combination of dose and treatment duration," said López-Bigas.

The researchers acknowledged some caveats in the study, including the accumulation of mutations in healthy tissues, and suggested that different tissues would be more susceptible than others, and risk can vary between individuals. Further studies that also sample healthy tissues will reveal more about how chemotherapy can damage healthy cells.

Sources: AAAS/Eurekalert! via Institute for Research in Biomedicine (IRB Barcelona), Nature Genetics

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
A DNA 'Stitch' as a Therapy for Duchenne Muscular Dystrophy
DMD is a genetic disorder that causes degeneration in muscles. Now there may be a treatment for as many as 47% of patients....
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
DEC 10, 2019
Cancer
DEC 10, 2019
Altered DNA methylation controls genes in cancer
New research published in the journal Genome Biology provide new information on genomic structural variation via DNA methylation and its connection to gene...
DEC 10, 2019
Cell & Molecular Biology
DEC 10, 2019
New RNA Observation Shows Previously Unkown Attachment to Sugar
Scientists in the Bertozzi at Staford University have published surprising observations of glycan sugars attached directly to RNA during glycosylation.&nbs...
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
Success in Treating Schizophrenia in Mice
Approximately 3.5 million people in the US have been diagnosed with schizophrenia. Although various therapies are available to treat and manage the illness...
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
Invasive Mussels are Taking Over Australia's Coastlines
Any type of organism that is not native to a location but ends up there anyway is considered an invasive species....
Loading Comments...